PDL BioPharma, Inc. Non-Controlling Interest

Non-Controlling Interest of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-Controlling Interest growth rates and interactive chart.

Highlights and Quick Summary

  • Non-Controlling Interest for the quarter ending June 29, 2020 was $-357 Thousand (a 23.96% increase compared to previous quarter)
  • Year-over-year quarterly Non-Controlling Interest increased by 96.15%
  • Annual Non-Controlling Interest for 2019 was $-280 Thousand (a 495.74% increase from previous year)
  • Annual Non-Controlling Interest for 2017 was $-47 Thousand (a -188.68% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-Controlling Interest of PDL BioPharma, Inc.

Most recent Non-Controlling Interestof PDLI including historical data for past 10 years.

Interactive Chart of Non-Controlling Interest of PDL BioPharma, Inc.

PDL BioPharma, Inc. Non-Controlling Interest for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.36 $-0.29
2019 $0.06 $-0.18 $-0.1 $-0.06 $-0.28
2017 $-0.05 $-0.05
2016 $0.06 $-0.0 $0.05

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.